Amoroso Michael
- SEC CIK
- 0001830874
In the past year, 3 open-market sale filings worth $246.2K and no purchases.
Current role at each company
- DTIL Precision Biosciences IncPresident and CEOas of Jun 3, 2026
- ABEO Abeona Therapeutics Inc.Directoras of Jan 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $246.2K
- 3 filings
- Net
- −$246.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Amoroso Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DTIL Precision Biosciences Inc
President and CEO11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Amoroso MichaelPresident and CEO | SSale | −20.6K | $3.84 | −$78.9K | −7.8%243.4K after | 10b5-1 |
| Jan 22, 2026 (view filing) | Jan 22 | Same day | Amoroso MichaelPresident and CEO | SSale | −34.8K | $4.17 | −$145.1K | −15.1%196.2K after | 10b5-1 |
| Nov 4, 2025 (view filing) | Nov 3 | 1 day | Amoroso MichaelPresident and CEO | SSale | −3.41K | $6.49 | −$22.1K | −2.9%115.6K after | 10b5-1 |
| Mar 25, 2025 (view filing) | Mar 24 | 1 day | Amoroso MichaelPresident and CEO | SSale | −964 | $5.56 | −$5.36K | −0.9%109.5K after | 10b5-1 |
| Jan 22, 2025 (view filing) | Jan 21 | 1 day | Amoroso MichaelPresident and CEO | SSale | −36.8K | $4.67 | −$172.0K | −25.6%107.1K after | 10b5-1 |
| Nov 5, 2024 (view filing) | Nov 4 | 1 day | Amoroso MichaelPresident and CEO | SSale | −3.01K | $8.19 | −$24.7K | −9.5%28.5K after | |
| May 3, 2024 (view filing) | May 2 | 1 day | Amoroso MichaelPresident and CEO | SSale | −1.53K | $10.32 | −$15.7K | −10.0%13.8K after | |
| Jan 23, 2024 (view filing)7:17 PM ET | Jan 22 | 1 day | Amoroso MichaelPresident and CEO | SSale | −137.4K | $0.36 | −$49.5K | −27.8%356.4K after | 10b5-1 |
| Nov 6, 2023 (view filing)5:07 PM ET | Nov 3 | 3 days | Amoroso MichaelPresident and CEO | SSale | −125.0K | $0.40 | −$50.0K | −35.5%227.1K after | 10b5-1 |
| Mar 23, 2023 (view filing) | Mar 22 | 1 day | Amoroso MichaelPresident and CEO | SSale | −47.0K | $0.82 | −$38.5K | −40.6%68.7K after | 10b5-1 |
ABEO Abeona Therapeutics Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Amoroso MichaelDirector | SSale | −5.51K | $3.91 | −$21.5K | −4.8%109.0K after | |
| Sep 22, 2023 (view filing) | Sep 20 | 2 days | Amoroso MichaelDirector | SSale | −327 | $3.90 | −$1.28K | −0.3%114.5K after | |
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | Amoroso MichaelDirector | SSale | −338 | $4.45 | −$1.50K | −0.3%114.8K after | |
| Mar 21, 2023 (view filing) | Mar 20 | 1 day | Amoroso MichaelDirector | SSale | −268 | $2.33 | −$624.44 | −0.5%56.4K after | |
| Mar 3, 2023 (view filing) | Mar 3 | Same day | Amoroso MichaelDirector | SSale | −1.00K | $2.38 | −$2.38K | −1.7%56.7K after | |
| Oct 4, 2021 (view filing) | Sep 30 | 4 days | Amoroso MichaelChief Executive Officer | SSale | −45.4K | $1.09 | −$49.5K | −7.0%604.6K after |